CP

Chandra Prabha Dubey

Active Director Director DIN 02899504
DIN 02899504 First appointment Jan 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2010
Shareholding value •••• Premium profile

About Chandra Prabha Dubey

Data last updated:

Chandra Prabha Dubey is a Director at Stedel Pharmaceuticals Private Limited (since 2010). The company operates in Trading. Stedel Pharmaceuticals Private Limited reported revenue of ₹22.2 Lakh (FY 2025).

DIN 02899504
Primary Designation Director
Industry Trading
First Appointment 08 Jan 2010
Oldest Company Age 16 yrs
Largest company Stedel Pharmaceuticals Private Limited · ₹22.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20102010₹22.2 Lakh (FY 2025)Active

Board colleagues of Chandra Prabha Dubey

NameDINCompanyDesignation
Arvind Kumar Dubey02899475Stedel Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Stedel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandra Prabha Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Prabha Dubey

Chandra Prabha Dubey currently holds 1 directorship: Stedel Pharmaceuticals Private Limited (Director, since 08 Jan 2010, revenue ₹22.2 Lakh (FY 2025)).

Chandra Prabha Dubey was first appointed on 08 Jan 2010 as Director at Stedel Pharmaceuticals Private Limited.

The current boards of Chandra Prabha Dubey's companies include Arvind Kumar Dubey (Stedel Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available